OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A new risk factor indicator for papillary thyroid cancer based on immune infiltration
Yang Zhou, Xiyi Wei, Yitong Pan, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 82
Yang Zhou, Xiyi Wei, Yitong Pan, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 82
Showing 1-25 of 82 citing articles:
The functional roles of the circRNA/Wnt axis in cancer
Chen Xue, Ganglei Li, Qiuxian Zheng, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 94
Chen Xue, Ganglei Li, Qiuxian Zheng, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 94
Understanding tumour endothelial cell heterogeneity and function from single-cell omics
Qun Zeng, Mira Mousa, Aisha Shigna Nadukkandy, et al.
Nature reviews. Cancer (2023) Vol. 23, Iss. 8, pp. 544-564
Closed Access | Times Cited: 87
Qun Zeng, Mira Mousa, Aisha Shigna Nadukkandy, et al.
Nature reviews. Cancer (2023) Vol. 23, Iss. 8, pp. 544-564
Closed Access | Times Cited: 87
TIM-3 as a promising target for cancer immunotherapy in a wide range of tumors
Natalia Sauer, Natalia Janicka, Wojciech Szlasa, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 11, pp. 3405-3425
Open Access | Times Cited: 66
Natalia Sauer, Natalia Janicka, Wojciech Szlasa, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 11, pp. 3405-3425
Open Access | Times Cited: 66
LAG-3 as a Potent Target for Novel Anticancer Therapies of a Wide Range of Tumors
Natalia Sauer, Wojciech Szlasa, Laura Jonderko, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9958-9958
Open Access | Times Cited: 53
Natalia Sauer, Wojciech Szlasa, Laura Jonderko, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9958-9958
Open Access | Times Cited: 53
Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma
Jiayang Cai, Yuanyuan Hu, Zhang Ye, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 45
Jiayang Cai, Yuanyuan Hu, Zhang Ye, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 45
TRAF2 promotes M2-polarized tumor-associated macrophage infiltration, angiogenesis and cancer progression by inhibiting autophagy in clear cell renal cell carcinoma
Yawei Xu, Lei Li, Wuping Yang, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 34
Yawei Xu, Lei Li, Wuping Yang, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 34
LAG-3 Inhibitors: Novel Immune Checkpoint Inhibitors Changing the Landscape of Immunotherapy
Rebecca Ibrahim, Khalil Saleh, Claude Chahine, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1878-1878
Open Access | Times Cited: 24
Rebecca Ibrahim, Khalil Saleh, Claude Chahine, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1878-1878
Open Access | Times Cited: 24
Identification a unique disulfidptosis classification regarding prognosis and immune landscapes in thyroid carcinoma and providing therapeutic strategies
Zhanrong Feng, Qian Zhao, Ying Ding, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 13, pp. 11157-11170
Open Access | Times Cited: 19
Zhanrong Feng, Qian Zhao, Ying Ding, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 13, pp. 11157-11170
Open Access | Times Cited: 19
Head-to-Head Comparison of [68Ga]Ga-DOTA.SA.FAPi and [68Ga]Ga-DOTANOC Positron Emission Tomography/Computed Tomography Imaging for the Follow-Up Surveillance of Patients with Medullary Thyroid Cancer
Sanjana Ballal, Madhav Prasad Yadav, Frank Roesch, et al.
Thyroid (2023) Vol. 33, Iss. 8, pp. 974-982
Closed Access | Times Cited: 18
Sanjana Ballal, Madhav Prasad Yadav, Frank Roesch, et al.
Thyroid (2023) Vol. 33, Iss. 8, pp. 974-982
Closed Access | Times Cited: 18
Current Status and Challenges of Vaccination Therapy for Glioblastoma
Hamed Hosseinalizadeh, Mohammad Rahmati, Ammar Ebrahimi, et al.
Molecular Cancer Therapeutics (2023) Vol. 22, Iss. 4, pp. 435-446
Closed Access | Times Cited: 14
Hamed Hosseinalizadeh, Mohammad Rahmati, Ammar Ebrahimi, et al.
Molecular Cancer Therapeutics (2023) Vol. 22, Iss. 4, pp. 435-446
Closed Access | Times Cited: 14
Emerging therapeutic options for follicular-derived thyroid cancer in the era of immunotherapy
Naimah Turner, Sarah Hamidi, Rim Ouni, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Naimah Turner, Sarah Hamidi, Rim Ouni, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Immune cells in thyroid adenoma and carcinoma: uncovering a hidden value of assessing tumor-host interplay and its potential application in thyroid cytopathology
Iryna Omelianenko, Nazarii Kobyliak, Tetyana Falalyeyeva, et al.
Frontiers in Molecular Biosciences (2025) Vol. 12
Open Access
Iryna Omelianenko, Nazarii Kobyliak, Tetyana Falalyeyeva, et al.
Frontiers in Molecular Biosciences (2025) Vol. 12
Open Access
Identification and analysis of oxidative stress-related genes in endometriosis
Chengmao Xie, Chang Lu, Na Lv, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Chengmao Xie, Chang Lu, Na Lv, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Cross-Talk Between Cancer and Its Cellular Environment—A Role in Cancer Progression
Eliza Turlej, Aleksandra Domaradzka, Justyna Radzka, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 403-403
Open Access
Eliza Turlej, Aleksandra Domaradzka, Justyna Radzka, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 403-403
Open Access
Transcriptome sequencing revealed that lymph node metastasis of papillary thyroid microcarcinoma is associated with high THBS4 expression and PDGFRA+ cancer-associated fibroblasts
Ling Hu, Yi Lin, Jie Zheng, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Ling Hu, Yi Lin, Jie Zheng, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Identification of Novel Cuproptosis-Related Genes Mediating the Prognosis and Immune Microenvironment in Cholangiocarcinoma
Qiang Liu, Jianpeng Zhu, Zhicheng Huang, et al.
Technology in Cancer Research & Treatment (2024) Vol. 23
Open Access | Times Cited: 3
Qiang Liu, Jianpeng Zhu, Zhicheng Huang, et al.
Technology in Cancer Research & Treatment (2024) Vol. 23
Open Access | Times Cited: 3
Identification of SUMOylation-related biomarkers in papillary thyroid carcinoma
Xiang Li, Zigang Ding, Yun Tong
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Xiang Li, Zigang Ding, Yun Tong
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Interplay of metabolic dysfunction-associated fatty liver disease and papillary thyroid carcinoma: insights from a Chinese cohort
Renyi Xiao, Qian Wang, Chunjue Ni, et al.
Journal of Endocrinological Investigation (2024) Vol. 47, Iss. 12, pp. 2943-2952
Closed Access | Times Cited: 3
Renyi Xiao, Qian Wang, Chunjue Ni, et al.
Journal of Endocrinological Investigation (2024) Vol. 47, Iss. 12, pp. 2943-2952
Closed Access | Times Cited: 3
Immune microenvironment in papillary thyroid carcinoma: roles of immune cells and checkpoints in disease progression and therapeutic implications
Xun Zheng, Ruonan Sun, Tao Wei
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Xun Zheng, Ruonan Sun, Tao Wei
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Identification of tumor antigens and immune subtypes in lower grade gliomas for mRNA vaccine development
Liguo Ye, Long Wang, Jian Yang, et al.
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 21
Liguo Ye, Long Wang, Jian Yang, et al.
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 21
Immune profiling identifies CD8+ T-cell subset signatures as prognostic markers for recurrence in papillary thyroid cancer
Zhen Chen, Mengli Guo, Ya-yi Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
Zhen Chen, Mengli Guo, Ya-yi Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
A unique regulated cell death-related classification regarding prognosis and immune landscapes in non-small cell lung cancer
Wei Su, Ting Hong, Baijie Feng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Wei Su, Ting Hong, Baijie Feng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
The Tumor Microenvironment and the Estrogen Loop in Thyroid Cancer
Nerina Denaro, Rebecca Romanò, Salvatore Alfieri, et al.
Cancers (2023) Vol. 15, Iss. 9, pp. 2458-2458
Open Access | Times Cited: 8
Nerina Denaro, Rebecca Romanò, Salvatore Alfieri, et al.
Cancers (2023) Vol. 15, Iss. 9, pp. 2458-2458
Open Access | Times Cited: 8
Identification of Tumor Antigens and Immune Landscape in Glioblastoma for mRNA Vaccine Development
Liguo Ye, Long Wang, Jian Yang, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 18
Liguo Ye, Long Wang, Jian Yang, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 18
New Insights into Immune Cells and Immunotherapy for Thyroid Cancer
Yujia Tao, Peng Li, Chao Feng, et al.
Immunological Investigations (2023) Vol. 52, Iss. 8, pp. 1039-1064
Closed Access | Times Cited: 7
Yujia Tao, Peng Li, Chao Feng, et al.
Immunological Investigations (2023) Vol. 52, Iss. 8, pp. 1039-1064
Closed Access | Times Cited: 7
